# Symptom-specific TMS Targets for Depression and Anxiety

> **NCT04604210** · PHASE2 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 40 (actual)

## Conditions studied

- Depression
- Anxiety
- Major Depressive Disorder

## Interventions

- **PROCEDURE:** Transcranial magnetic stimulation

## Key facts

- **NCT ID:** NCT04604210
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-03
- **Primary completion:** 2023-12-28
- **Final completion:** 2023-12-28
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04604210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04604210, "Symptom-specific TMS Targets for Depression and Anxiety". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04604210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*